by Jordana Choucair | Oct 24, 2022 | Life Sciences
Pfizer plans to increase the price of its COVID-19 vaccine to between $110 to $130 per dose once the U.S. government’s purchasing program ends early next year. The price is roughly four times what the federal government pays per dose ($30). According to a Pfizer...
by Jordana Choucair | Oct 24, 2022 | Life Sciences
Peter Marks, the Food and Drug Administration’s vaccines chief, said in an interview that he’s worried about the possibility of deploying another COVID-19 booster before next September or October because of the speed at which the virus is evolving. Marks...
by Jordana Choucair | Oct 24, 2022 | M&A
Federal Trade Commission (FTC) Chair Lina Khan said the agency is “looking closely at the role of private equity” in health deals, especially when investors purchase several businesses in the same industry. Examining roll-up transactions by private equity...
by Jordana Choucair | Oct 24, 2022 | Opioid/Substance Use Disorders
Senator Dick Durbin and Representative Lauren Underwood wrote a letter urging the Centers for Medicare & Medicaid Services (CMS) to expand Medicare’s coverage of substance use disorder (SUD) to address key gaps exacerbating the addiction crisis. The lawmakers...
by Jordana Choucair | Oct 24, 2022 | Providers
According to the Health Resources and Services Administration’s (HRSA) fourth quarter Designated Health Professionals Shortage Area (HPSA) report data, only 27.7 percent of mental health professionals needed are available. The report also found that six states –...
Recent Comments